Indaptus Therapeutics, Inc. (INDP)

CIK 1857044 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Indaptus Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 20268-K0001493152-26-042037
Sep 8, 20268-K/A0001493152-26-041636
Sep 4, 20268-K0001493152-26-041532
Sep 4, 2026424B50001493152-26-041526
Sep 1, 20268-K0001493152-26-040926
Aug 31, 2026424B50001493152-26-040751
Aug 26, 2026424B30001493152-26-040246
Aug 25, 2026EFFECT9999999995-26-002761
Aug 17, 2026S-30001493152-26-038780
Aug 13, 202610-Q0001493152-26-037579
Aug 13, 20268-K0001493152-26-037574
Jul 17, 2026EFFECT9999999995-26-002348
Jul 16, 2026DEF 14A0001493152-26-033545
Jun 26, 2026SCHEDULE 13D/A0001829126-26-006953
Jun 26, 2026SCHEDULE 13D/A0001829126-26-006951
Jun 26, 2026SCHEDULE 13D/A0001829126-26-006950
Jun 26, 2026SCHEDULE 13D/A0001829126-26-006949
Jun 26, 2026S-30001493152-26-030346
Jun 24, 20268-K0001493152-26-029918
Jun 22, 2026PRE 14A0001493152-26-029633
Jun 5, 20268-K0001493152-26-027499
May 15, 20268-K0001493152-26-023344
May 15, 202610-Q0001493152-26-023362
Apr 29, 2026SCHEDULE 13D/A0001829126-26-004104
Apr 24, 20268-K/A0001493152-26-018954